BCLI - BrainStorm Cell Therapeutics Operating income before deduction of amortization
Brainstorm Cell (BCLI) is developing cell therapy to combat ALS while facing risks of clinical trial failure and capital shortages. The business's stable humanitarian status minimizes external threats, and the GURU.Markets service calculates quarterly EBITDA, where the figure remains around . However, geopolitical fractures and sanctions could complicate the international logistics of biomaterials and slow down global development.
Summary analytical data breakdowns for BrainStorm Cell Therapeutics (BCLI)
- market price and analyst price targets:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Aggregate Debt to Capital Brainstorm Cell|BCLI - Long-Term Debt to Equity|Current Liabilities to Capital Brainstorm Cell Therapeutics Inc.|BCLI - Company Debts|Debt to Net Assets Ratio BrainStorm Cell Therapeutics|BCLI - Company Long-Term Debt|Company Current Liabilities BrainStorm Cell Therapeutics|Intermediate Coverage Ratio brainstorm-cell.com
- earnings and valuation multiples indicators:
BCLI - Net Profit|Future Profit Brainstorm Cell|BCLI - P/E Multiple|Projected Price to Earnings Ratio brainstorm-cell.com|BCLI - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BrainStorm Cell Therapeutics|BCLI - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months BrainStorm Cell Therapeutics|BCLI - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months brainstorm-cell.com|BCLI - Earnings growth in current year|Expected earnings per share growth for next year Brainstorm Cell
Analysis of all company metrics:BrainStorm Cell Therapeutics Inc.
Brainstorm Cell (BCLI) strategic alliances in NurOwn cell therapy reduce merger risks by creating synergy with leading clinics. An analysis of the EBITDA metric digitizes this process by measuring real operating cash flow excluding depreciation and taxes, allowing investors to compare the current cost of capital with historical retrospectives to identify asset overvaluation.
Competitors of Brainstorm Cell (BCLI)
Operating profit EBITDA Biogen Idec BIIB|Neurocrine Biosciences - Operating profit EBITDA|Operating income before deduction of amortization regencellbioscience.com RGC|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ACAD|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Viking Therapeutics Corp (VKTX) - Operating income before deduction of amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|Company profit before taxes, interest and amortization CPRX|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization praxismedicines.com|Operating profit before deduction of amortization AVXL|CBLL: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PRTA|Operating profit before deduction of amortization alector.com ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Omeros Corp (OMER) - Profit before interest, taxes and amortization|NGNE - Profit before payment of interest, taxes and amortization|ACIU: Profit before payment of interest, taxes and amortization|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|NMRA (Neumora Corp) - Profit before payment of interest, taxes and amortization|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization TVGN|Operating profit EBITDA ACOG|Operating profit before deduction of amortization Cognition Therapeutics Inc. CGTX|Profit before payment of interest, taxes and amortization Inhibikase IKT|Cassava Pharma - Profit before payment of interest, taxes and amortization|Assertio Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|Operating profit before amortization OVID|ABOS (Acumen Pharma) - Operating profit EBITDA|Profit before interest, taxes and amortization CervoMed Corporation CRVO|Operating profit before deduction of amortization ATHE (Alterity Therapeutics)|Operating profit EBITDA clene.com (CLNN)|Profit before payment of interest, taxes and amortization PepGen PEPG|Income before deduction of interest, taxes and amortization JUNS|RLMD - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Annovis Bio Corporation|GRCE: Operating profit EBITDA|AIFF (fireflyneuro.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANEW Medical|NRSN: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RVPH|Operating profit EBITDA metaviatx.com (MTVA)|Operating profit EBITDA NRXS (NeurAxis, Inc.)|Operating income before deduction of amortization Helius Medical Technologies, Inc. (HSDT)|PASG - Profit before payment of interest, taxes and amortization|NEUP (Neuphoria Therapeutics Inc.) - Operating profit before amortization|Minerva Neurosciences Corp (NERV) - Profit before payment of interest, taxes and amortization|ATHA - Operating income before deduction of amortization|Operating profit before deduction of amortization ADXN|ALZN (Alzamend) - Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|PTIX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Pasithea Therapeutics Corp. KTTA|Income before deduction of interest, taxes and amortization CRGT|ATXI - Profit before payment of interest, taxes and amortization|caratherapeutics.com (CARA) - Operating profit before deduction of amortization|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Longboard (LBPH)|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Sage Therapeutics Inc. - Profit before payment of interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|TRVN: Profit before payment of interest, taxes and amortization|VIGL: Operating profit EBITDA|WENA (anewmeds.com) - Profit before payment of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
